VENUS REMEDIES LTD. - 526953 - Board Meeting Intimation for Notice Of Board Meeting To Be Held On Dated 6Th November, 2020.
VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2020 ,inter alia, to consider and approve Notice of Board meeting to be held on dated 6th November, 2020. VENUS REMEDIES LTD. - 526953 - Reg 40 (10) Compliance For The Quarter Ended On 30Th Sep 2020.
Reg 40 (10) compliance for the quarter ended on 30th Sep 2020. VENUS REMEDIES LTD. - 526953 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance under reg 74(5) of SEBI (DP) Regulations. VENUS REMEDIES LTD. - 526953 - Compliance Certificate Under Regulation 7(3) For The Quarter Ended September 2020.
compliance certificate under regulation 7(3) for the quarter ended September 2020. VENUS REMEDIES LTD. - 526953 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- NehaDesignation :- Company Secretary and Compliance Officer VENUS REMEDIES LTD. - 526953 - Shareholding for the Period Ended September 30, 2020
Venus Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here VENUS REMEDIES LTD. - 526953 - Closure of Trading Window
Pursuant to the Code of Conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, this is to inform that the trading window for dealing in equity shares of the Company shall remain closed for all Designated Persons of the Company, as defined under the said Regulations, from October 1, 2020 till 48 hours from the declaration of the Unaudited Financial Results for the Quarter ending September 30, 2020 VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication
newspaper publication of Unaudited Financial Results for the quarter ended on 30.06.2020 VENUS REMEDIES LTD. - 526953 - Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of The SEBI ( Listing Obligations & Disclosures Requirements) Regulations, 2015
Pursuant to regulation 23(9) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015, kindly find enclosed herewith a disclosure on related party transaction on Consolidated basis, as per the format specified in Accounting Standards for the year ended on 31st March 2020. 